Medical Oncologist Neeta Somaiah Joins Fox Chase Cancer Center
Philadelphia (July 16, 2009) – Medical oncologist Neeta Somaiah, MD, has joined Fox Chase Cancer Center as an attending physician in the medical oncology department. At Fox Chase, Somaiah will treat patients with bone and soft tissue sarcomas and lung cancers in addition to performing perform clinical research.
“The set up at Fox Chase not only allows me to perform meaningful research but also enables me to provide the best possible care to my patients,” Somaiah says. “The top-notch multidisciplinary team, skilled nursing, support services for patients and their families and excellent research/clinical trial options, are all crucial for the most favorable outcome in our patients.”
Somaiah joins the Center after completing her fellowship in hematology and medical oncology at Fox Chase. A member of Fox Chase’s Research Review Committee, Somaiah has also worked in the Tumor Cell Biology Program at Fox Chase. She is a member of the American Society of Clinical Oncology, American Association of Cancer Research and American Society of Hematology.
“I chose two of the most challenging types of cancer to treat — sarcoma and lung cancer. One is rare, while the other is common, but both cause significant morbidity and mortality,” notes Somaiah. “I hope with my energy and dedication, I can make a positive contribution to the care of these patients at Fox Chase.”
Somaiah spent a year at Temple University as part of her 3-year hematology/oncology fellowship. Prior to that, she earned her MD in internal medicine from Drexel University College of Medicine, also in Philadelphia, in 2004. In 2001, Somaiah graduated from Maulana Azad Medical College, Delhi University, India.
Among her honors, Somaiah graduated amongst the top 1 percent of her medical school class, and was the recipient of the prestigious scholarship by the Government of India (National Talent Search) for her entire medical education (given to a total of 50 students in different fields each year).
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.